[The return of germline gene therapy]

Bertrand Jordan1

  • 1UMR 7268 ADÉS, Aix-Marseille, Université/EFS/CNRS, Espace éthique méditerranéen, hospital d'adultes la Timone, 264, rue Saint-Pierre, 13385 Marseille Cedex 05, France - CoReBio PACA, case 901, parc scientifique de Luminy, 13288 Marseille Cedex 09, France.

Medecine Sciences : M/S
|July 9, 2015
PubMed
Summary

The CRISPR-Cas9 gene editing tool rapidly advances animal model creation and gene therapy. However, it also presents significant ethical challenges regarding human germline modification, demanding immediate attention.